Patents by Inventor Nancy Joseph-Ridge

Nancy Joseph-Ridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140329868
    Abstract: The present invention relates to methods of treating subjects suffering from pre-hypertension or hypertension by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: April 7, 2014
    Publication date: November 6, 2014
    Inventors: Christopher Lademacher, Lin Zhao, Nancy Joseph-Ridge, Richard Johnson
  • Patent number: 8841333
    Abstract: The present invention relates to methods of treating subjects suffering from nephrolithiasis by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: September 23, 2014
    Assignee: Takeda Pharmaceuticals U.S.A., Inc.
    Inventor: Nancy Joseph-Ridge
  • Publication number: 20090042887
    Abstract: The present invention relates to methods of preventing gout flares in a subject in need thereof by administering to the subject a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof and at least one non-steroidal anti-inflammatory drug for a period of six months on a regular basis.
    Type: Application
    Filed: January 17, 2008
    Publication date: February 12, 2009
    Applicant: TAP Pharmaceutical Products, Inc.
    Inventors: Christopher Lademacher, Patricia McDonald, Nancy Joseph Ridge, Rajneesh Taneja
  • Publication number: 20070167454
    Abstract: The present invention relates to methods of treating subjects suffering from pre-hypertension or hypertension by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: August 2, 2006
    Publication date: July 19, 2007
    Inventors: Christopher Lademacher, Lin Zhao, Nancy Joseph-Ridge, Richard Johnson
  • Publication number: 20060252808
    Abstract: The present invention relates to methods of treating subjects suffering from nephrolithiasis by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: May 8, 2006
    Publication date: November 9, 2006
    Inventor: Nancy Joseph-Ridge